Purpose
to provide guidance to decision makers regarding the risks vs benefits of use of dolutegravir for treating women of childbearing age who are living with HIV
Grantee
Division
Global Health
Date
SEPTEMBER 2018
Region served
GLOBAL
Committed amount
$70,830
Grant topic
HIV
Duration (months)
9
Grantee location
Geneva, Switzerland
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.